For subscribers
China’s pharma dominance is just beginning
As with anything at the intersection of the US and China, geopolitics is likely to come into play.
Sign up now: Get ST's newsletters delivered to your inbox
China is putting technology, including pharmaceuticals, front and centre of its economic plan.
PHOTO: EPA
Juliana Liu
The old pharmaceutical order anchored around cutting-edge advances from the West has quietly disappeared. What we have now is a bipolar industry centred on the US and China – with implications for patients and policymakers worldwide.
China has closed the gap on the number of research studies being conducted and, in certain cases, even moved ahead on developing new treatments.
